viimane versioon :
19/11/2024
uurimisrühmad - Faculty of Pharmacy    pdf  
Poola
ülikool
Faculty of Pharmacy
Poznan
Viited   Viited   (14)  
1
Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration.
Dettlaff K, Gostyinska A, Ziółkowska N, Stawny M. (dettlaff@ump.edu.pl)
Pharmaceutics - 2024 - ; 14, 2570.
2
Antiemetic Drugs Compatibility Evaluation with Paediatric Parenteral Nutrition Admixtures.
Tomczak S, Chmielewski, M, Szkudlarek J, Jeliinska A. (szymon.tomczak@ump.edu.pl)
Pharmaceutics - 2023 - ; 15: 2143.
3
Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures.
Gostynska A, Piwowarczyk L, Nadolna M, Jelinska A, Dettlaff K, Ogrodowczyk M, Popielarz-Brzezinska M, Stawny M. (mstawny@ump.edu.pl)
Antibiotics - 2021 - ; 10, 217.
4
Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron
Tomczak S, Radwan V, Jelinska A, Stawny M. (szymon.tomczak@ump.edu.pl)
Processes - 2021 - , 9, 453.
5
Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition
Stawny M, Gostyńska A, Nadolna M, Jelińska A. (mstawny@ump.edu.pl)
Pharmaceutics - 2020 - ; 12: 292
6
The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures.
Gostynska, A, Stawny M, Dettlaff K, Jelinska A. (ajelinsk@ump.edu.pl)
Pharmaceutics - 2020 - ; 12, 27
7
Stability studies of parenteral nutrition with a high dose of vitamin C.
Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M. (mstawny@ump.edu.pl)
J Oncol Pharm Practice - 2020 - ;26,8:1894–1902
8
9
Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition.
Stawny M, Gostynska A, Dettlaff K, Jelinska A, Główka E, Ogrodowczyk M. (mogrodo@ump.edu.pl)
Nutrients - 2019 - ; 11: 559.
10
Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition.
Tomczak S, Stawny M, Dettlaff K, Kieliszek, M, Słominska D, Jelinska A. (szymon.tomczak@ump.edu.pl)
Molecules - 2019 - 24, 1242.
11
Stability of cefpirome sulfate in aqueous solutions.
Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J. (pzalewski@ump.edu.pl)
Acta Pol Pharm - 2016 - ; 73, 1: 23-27.
12
Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska. (bstanisz@ump.edu.pl)
Acta Pol Pharm - 2014 - ; 71, 4: 661-666.
13
Stability of ertapenem in aqueous solutions.
Zajac M, Cielecka-Piontek J, Jelinska A. ()
J Pharm Biomed Anal - 2007 - ; 43: 445-449.
14
Stability of aztreonam in AZACTAM.
Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I. (mzajac@amp.edu.pl )
Il Farmaco - 2005 - ; 60: 599-603.

ingredientide nimekiri   molekulid uuritud   (16)  
antibiootikum Süsteravim Ampicillin sodium
vitamiin Süsteravim Ascorbic acid
antibiootikum Süsteravim Aztreonam
antibiootikum Süsteravim Cefpirome sulfate
Antihüpertensiivne ravim suukaudne lahus Cilazapril
antibiootikum Süsteravim Ciprofloxacin lactate
antibiootikum Süsteravim Colistin mesilate sodium
Põletikuvastane ravim Süsteravim Dexamethasone sodium phosphate
antibiootikum Süsteravim Ertapenem
diureetikum Süsteravim Furosemide
Põletikuvastane ravim Süsteravim Hydrocortisone sodium succinate
Põletikuvastane ravim Süsteravim Ketoprofene
antibiootikum Süsteravim Linezolid
antibiootikum Süsteravim Meropenem
antiemeetikum Süsteravim Ondansetron hydrochloride
diureetikum Süsteravim Torsemide

  Mentions Légales